Upcoming Allied Market Research
Clinical Trial Supply And Logistics Market

Clinical trial supply and logistics market - Global Opportunity Analysis and Industry Forecast, 2021-2031 Market

Report Code: A08192
Pages: NA
Mar 2023 | 2066 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Clinical Trial Supply And Logistics Market

Request Now !

Clinical trials are research studies performed in a group of people called sample that are aimed at evaluating a medical, surgical, or behavioral intervention. It is a primary way for researchers to measure safety, efficacy, side effects and positive effects of new treatment, new drug, medical device or test cancer therapies, treatments for cardiovascular disease, the safety and efficacy of new therapies and a number of other conditions on sample. Clinical trials are sponsored and funded by government agencies, institutions, hospitals, physicians, pharmaceutical or biotechnology companies, advocacy groups, or other organizations. It is a crucial step before launching a new drug or product into market. One important factor in successfully conducting clinical studies is the efficient management of clinical trial supplies, particularly for those complex studies requiring detailed monitoring, precise planning, and coordination between many players. Demands for increasingly complex and expensive clinical trials have forced drug developers to look to supply service providers to source clinical trial materials and deliver them to operational sites.


COVID – 19 scenario analysis:  

  • Due to the ongoing COVID – 19 pandemic, more than to four million infected people and the affected economies continue to struggle, as COVID-19 has impacted several industries including clinical trails supply and logistics  as well 
  • With flights grounded and businesses at loss, the participants of trials are not leaving their homes has made continuing clinical trials extremely difficult 
  • A report published recently, in which nearly 30 percent of surveyed clinical trial sites, said that the novel coronavirus will have a huge impact on their ability to recruit patients for new trials and to keep patients enrolled for in-progress trials intact with their study schedules 
  • The same report highlighted 56% of U.S. clinical research study sites and 81 percent of European sites indicated already-enrolled patients are probably not willing to continue in clinical trials and this discontinuation would affect the clinical trial supply and logistics as well 
  • As of March 30, 2020; nearly 30 biotech and pharma companies have reported a disruption to clinical trials and its supply and logistics as a result of the crisis

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Demand for biological and orphan drugs will be one of the factors that drive the clinical trial supply and logistics market. There is rise in development of new drug, therapies and medical devices which is going to supplement the growth of the market. Technological advances occurring in pharmaceutical and biologics, especially in areas of testing and development of new medical procedures, products, drugs and experiments, is heavily responsible for driving the global clinical trial supply and logistics market. Furthermore, many companies are immensely investing to bring advanced logistics and technologies in clinical trial activities in cycle, consequently spiking supply of the necessary equipment. In addition to this, several governments are encouraging to carry out ethical clinical trial activities which will lead to the betterment of mankind. Thus, the global clinical trial supply and logistics market is expected to expand with immense growth in near future. Simultaneously, the increasing emphasis by the manufacturers towards minimizing overage incidences and avoiding shortages, optimizing production and packaging, and balancing shipment and supply costs are increasing the demand for efficient clinical trial supply and logistics. On the contrary, high expenses in arranging for patients, equipment needed to carry on ethical clinical trials and lack of necessary expertise to execute such activities as well as time consumption are the major factors hampering the clinical trial supply and logistics market. Many players wiling to expand into unexplored market would be likely facing these issues.

Increasing innovations in Clinical trial supply and logistics

The supply and logistics provider as well as pharmaceutical and biotech firms engaged in coming up with alternative site solutions and utilizing more innovative approaches are critical to keeping trials moving forward to prevent delays in therapies and ultimately, to the patients who can benefit from them. This pandemic has been the first time there has been a global disruption to traditional onsite clinical trials. The U.S Food and Drug Administration (FDA), the National Institutes of Health (NIH), the European Medicines Agency (EMA), China’s National Medical Products Administration and several other countries have issued several guidelines pertaining to the conduct of trials during the pandemic and are in support of incorporating virtual services. 

Adopting direct-to-patient (DTP)/direct-from-patient (DFP) services can resolve challenges, which may also include quarantines and travel bans, site closings, and protecting patients and site staff. Such services can keep clinical trials running and patients safe by making treatments, diagnostic tests shipped directly to them at home. Via DFP services, biological samples can be collected from patient’s home and sent to laboratory for testing. Integrating DTP/DFP includes use of tracking technologies to update patient location and home deliveries and pick-up. 

Pharmaceutical and Biotech firms entering into strategic partnerships with Supply and logistics providers and CROs

With the aim of increasing profit margins and expansion of the product portfolio to new markets, pharmaceutical and biopharmaceutical companies are entering in strategic agreements for better distribution channels and better reach to the customers and outsourcing clinical trial supply and logistics activities to CROs. Many companies trying to expand in developing geographies are also outsourcing to supply and logistics services provider for better market reach. For example, the cost of clinical trials in China is roughly 20% less than what it is in the US. It has resulted in reduced expenditures and increased investments in R&D to conduct clinical trials. The demand for efficient supply and logistics of trial samples between pharma companies, the food and drug administration, and CROs will continue to drive the market in the years to come.  As a result, the clinical trial supply and logistics market is expected to make significant gains. 

Key benefits of the report:

  • This study presents the analytical depiction of the global clinical trial supply and logistics industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global clinical trial supply and logistics market market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the global clinical trial supply and logistics market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global clinical trial supply and logistics market market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Clinical Trial Supply and Logistics Market research report:

  • Who are the leading market players active in the clinical trial supply and logistics market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?

Clinical trial supply and logistics market - Global Opportunity Analysis and Industry Forecast, 2020-2027 Report Highlights

Aspects Details
By Component
  • Manufacturing
  • Packaging
  • Distribution
By Type
  • Virtual service providers
  • Courier and delivery service providers
By End User
  • Pharmaceutical and biotech organizations
  • Medical devices and supplier companies
By Region
  • North America  (US, Canada, Mexico)
  • Europe  (France, Germany, UK, Italy, Spain, rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, rest of Asia-Pacific)
  • LAMEA  (Brazil, South Arabia, South Africa, rest of LAMEA)
Key Market Players World Courier, DHL, Movianto, Catalent, Patheon, Marken, FedEx, Almac Group, Parexel International, Fisher Clinical Services, Packaging Coordinators Inc.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Clinical Trial Supply And Logistics Market

Start reading.
This Report and over 19,614+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers